A detailed history of Affiance Financial, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Affiance Financial, LLC holds 3,468 shares of ABT stock, worth $396,149. This represents 0.1% of its overall portfolio holdings.

Number of Shares
3,468
Previous 3,468 -0.0%
Holding current value
$396,149
Previous $360,000 9.72%
% of portfolio
0.1%
Previous 0.1%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 11, 2023

SELL
$95.53 - $114.62 $16,144 - $19,370
-169 Reduced 4.65%
3,468 $335,000
Q2 2023

Jul 11, 2023

BUY
$100.78 - $112.29 $16,427 - $18,303
163 Added 4.69%
3,637 $396,000
Q4 2022

Jan 20, 2023

BUY
$95.06 - $111.52 $7,699 - $9,033
81 Added 2.39%
3,474 $0
Q2 2022

Jul 14, 2022

SELL
$102.07 - $123.37 $81,656 - $98,696
-800 Reduced 19.08%
3,393 $369,000
Q1 2022

Apr 12, 2022

SELL
$114.02 - $139.04 $1,938 - $2,363
-17 Reduced 0.4%
4,193 $496,000
Q4 2021

Feb 01, 2022

SELL
$115.53 - $141.46 $4,621 - $5,658
-40 Reduced 0.94%
4,210 $593,000
Q1 2021

Apr 21, 2021

SELL
$108.84 - $128.23 $979 - $1,154
-9 Reduced 0.21%
4,250 $509,000
Q4 2020

Jan 25, 2021

BUY
$105.0 - $114.42 $12,180 - $13,272
116 Added 2.8%
4,259 $466,000
Q3 2020

Oct 13, 2020

SELL
$91.64 - $111.29 $3,573 - $4,340
-39 Reduced 0.93%
4,143 $451,000
Q4 2019

Jan 16, 2020

SELL
$78.51 - $87.4 $17,115 - $19,053
-218 Reduced 4.95%
4,182 $363,000
Q4 2017

Jan 16, 2018

SELL
$53.68 - $57.47 $8,052 - $8,620
-150 Reduced 3.3%
4,400 $251,000
Q1 2017

Dec 08, 2017

BUY
N/A
4,550 New
4,550 $202,000
Q1 2016

Dec 08, 2017

SELL
N/A
-4,864 Closed
0 $0
Q4 2015

Dec 11, 2017

SELL
N/A
-590 Reduced 10.82%
4,864 $218,000
Q3 2015

Dec 08, 2017

SELL
N/A
-185 Reduced 3.28%
5,454 $219,000
Q4 2014

Dec 08, 2017

BUY
N/A
5,639
5,639 $254,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Affiance Financial, LLC Portfolio

Follow Affiance Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affiance Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affiance Financial, LLC with notifications on news.